Effects of ATP and ATP inhibitors on the P2X7 receptor by Salzbrenner, Holly Marie
University of Northern Iowa
UNI ScholarWorks
Honors Program Theses University Honors Program
2015
Effects of ATP and ATP inhibitors on the P2X7
receptor
Holly Marie Salzbrenner
University of Northern Iowa
Copyright © 2015 Holly Marie Salzbrenner
Follow this and additional works at: https://scholarworks.uni.edu/hpt
Part of the Biology Commons, and the Meat Science Commons
Let us know how access to this document benefits you
This Open Access Honors Program Thesis is brought to you for free and open access by the University Honors Program at UNI ScholarWorks. It has
been accepted for inclusion in Honors Program Theses by an authorized administrator of UNI ScholarWorks. For more information, please contact
scholarworks@uni.edu.
Recommended Citation
Salzbrenner, Holly Marie, "Effects of ATP and ATP inhibitors on the P2X7 receptor" (2015). Honors Program Theses. 158.
https://scholarworks.uni.edu/hpt/158
 EFFECTS OF ATP AND ATP INHIBITORS  
ON THE P2X7 RECEPTOR 
 
 
 
 
 
 
A Thesis Submitted 
in Partial Fulfillment  
of the Requirements for the Designation 
University Honors 
 
 
 
 
 
 
 
 
Holly Marie Salzbrenner 
University of Northern Iowa 
May 2015 
 
 
  
ii 
 
This Study by: Holly Salzbrenner 
Entitled: EFFECTS OF ATP AND ATP INHIBITORS ON THE P2X7 RECEPTOR 
 
 
 
has been approved as meeting the thesis or project requirement for the Designation 
University Honors 
 
 
 
_____________                                _____________________________________________ 
Date                                                      Dr. David McClenahan, Honors Thesis Advisor, Biology 
 
_____________                                _____________________________________________ 
Date                                                      Dr. Jessica Moon, Director, University Honors Program 
 
  
iii 
 
 
Table of Contents 
Section                                                                                                                 Page Number 
Abstract…………………………………………………………………………...……....iv 
Acknowledgements……………………………………………………………………….v 
Introduction……………………………………………………………………………….1 
Literature Review……………………………………………………...…………………..1 
Materials and Methodology…………………………………………………....………….5 
Results……………….………………………………………………………………........12 
Discussion…………………………………………………………………….………..….15 
Conclusion…………………………………………………………………………..…….18 
Appendix………………………………………………………………………………….21 
Literature Cited……………………………………………………………………………23 
  
iv 
 
Abstract 
 Extracellular ATP has been shown to increase the permeability of cells via the P2X7 
receptor. This relationship could be important in understanding the physiology of the 
inflammation that occurs in bovine respiratory disease complex (BRDC). My research involved 
testing to see if this relationship between ATP and the P2X7 receptor is present. Then, potential 
inhibitors of ATP were tested so they can be used in further research involving ATP and BRDC. 
To test bovine cells, Mac-T cells were treated with ATP and incubated for various periods of 
time before Yo-Pro (a fluorescent molecule) was added. The percent change in fluorescence 
between cells with and without ATP determined the ability ATP had in opening the P2X7 
receptor pore. Results showed that extracellular ATP does bind to the P2X7 receptor to open 
pores. In general, the greatest change in fluorescence was seen when ATP was incubated for at 
least 45 minutes before the Yo-Pro was added. The actual incubation time where the greatest 
change in fluorescence value occurred was 60 minutes.  In addition, the results from the 
experiments with inhibitors A were insignificant; therefore no conclusions could be made at this 
time.  
Keywords: ATP, Yo-Pro, P2X7, Inhibitor A438079, and Inhibitor KN 
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Introduction 
 The purpose of this research was to help address the relationship between the P2X7 
receptor and its ligand, ATP. This relationship may have an important role in the physiology of 
bovine respiratory disease complex (BRDC), which is a very common disease affecting cattle 
lots. The cattle (bovine) industry supplies a large amount of beef to our food supply so our food 
supply depends on how well BRDC is diagnosed and treated. To be able to better diagnose and 
treat BRDC, we need to understand the physiology of the disease. In other words, we need to 
know how the disease is caused and how it thrives in the bovine body. In order to further 
understand the important role between the P2X7 receptor and ATP, inhibitors of the P2X7 
receptor are needed to block ATP to be able to investigate the effects ATP has in inflammation 
occurring during BRDC, which is crucial to the success of the disease in making a bovine sick. 
We can compare the changes ATP makes to cells to the changes made when ATP is blocked 
specifically at the P2X7 receptor. Currently, inhibitors A438079 and KN62 have been used to 
block P2X7 receptors in humans, but they needed to be tested in bovine cells. First, it had to be 
determined that bovine cells actually show an increase in permeability, or leakage, caused by 
extracellular ATP before the inhibitors could be tested so a change could be observed between 
no inhibitors and the use of inhibitors. 
 
Literature Review 
 Bovine Respiratory Disease Complex (BRDC), also known as shipping fever, is one of 
the most prominent issues in managing cattle health because it is responsible for over 50% of 
deaths in cattle feedlots and reduces the growth performance of cattle (Regev-Shoshani, 
Vimalanathan, Prema, Church, and Reudink et al., 2014). BRDC occurs as an infection of the 
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alveolar epithelium, which is the tissue in the air sacs of the lung (Narayanan, Kumar, Nagaraja, 
Chengappa, and Stewart, 2002). Mannheimia haemolytica, the main bacterial pathogen for 
BRDC, is a gram-negative coccobacillus with two main virulence factors (proteins that are on 
the bacteria’s surface that are identified by a host’s immune system as foreign object), 
lipopolysaccharides and leukotoxins. These factors cause apoptosis (cell death caused by the cell 
itself) at low concentrations and necrosis (cell death) at high concentrations in macrophages and 
neutrophils (immune cells) of lung tissues. Cell necrosis is associated with the airways becoming 
clogged with fluid and cellular debris, such as platelets and erythrocytes, from blood vessels and 
inflamed alveoli (Zecchinon, Fett, and Desmecht, 2005). These two processes limit proper 
respiratory function and can lead to death in bovines.  
Recent studies have been investigating how macrophage and neutrophil cell death results 
in fluid leakage (caused by increased cell permeability) and inflammation in the lung. It is 
already known that neutrophils will activate proinflammatory cytokines, but new information has 
shown that leukotoxin binding can trigger signaling cascades that activate voltage-gated channels 
and oxygen-derived free radicals; both of which have a role in the lysis of cells and activation of 
immune complexes (Zecchinon et al., 2005). In addition, lipopolysaccharides increase 
endothelial cell cytotoxicity and neutrophil degranulation, which causes endothelial damage 
(McClenahan, Evanson, and Weiss, 2002). Hence, it is not the leukotoxins and 
lipopolysaccharides that directly cause lung damage; it is their interaction with the immune 
system, specifically the over activation of neutrophils and macrophages, that enables the bacteria 
to successfully survive in the host tissue (Zecchinon et al., 2005). Therefore, it is crucial to study 
the pathogenesis of this interaction to fully understand BRDC. 
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As mentioned previously, lipopolysaccharides and leukotoxins play roles in triggering the 
beginning of this pathway by activating neutrophils and macrophages, which is the pathway 
typical of an immune response to a foreign antigen. This eventually causes them to undergo cell 
death via apoptosis or necrosis. However, they do not directly cause the initial leakage of blood 
components into the alveoli because they do not directly increase permeability in epithelial cells 
(Craddick, Patel, Lower, Highlander, and Ackermann, 2012). Instead, neutrophils, macrophages, 
and other cells that underwent necrosis released adenosine triphosphate (ATP), the energy 
molecule for cells, when they were lysied, or destroyed. This extracellular ATP potentially 
causes an increase in cell permeability, or vascular leakage. This can allow blood components, 
such as platelets and immune complexes, into the airways and alveoli. Thus, ATP can be 
regarded as an extracellular mediator of inflammation (Craddick et al., 2012). Additionally, it 
has been shown that ATP increases cell permeability in bovine cells as well, specifically bovine 
pulmonary epithelial (BPE) cells and bovine pulmonary microvascular endothelial cells 
(BPMEC) by activating the P2X7 receptor (McClenahan, Hillenbrand, Kapur, Carlton, and 
Czuprynski, 2009). 
The P2X7 receptor is homomeric, meaning several of the same subunits make up the 
channels, and is a type of purinergic receptor of the P2X family. This family is a class of 
membrane ion channels where extracellular ATP serves as the agonist, has the ability to bind and 
activate. In addition, high concentrations of ATP are required to activate the receptor since it is 
not very sensitive to ATP. Plus, the presence of divalent ions can allosterically inhibit ATP 
binding. The main function of P2X7 makes the cell membrane permeable to small monovalent 
cations and to larger, organic molecules, such as the fluorescent dye Yo-Pro (North, 2002). 
Actually, membrane permeability to larger molecules increases with the amount of time ATP is 
4 
 
bound, which can be explained by the following mechanism. When one ATP binds to a P2X7 
subunit, it causes an asymmetrical orientation that deters the binding of the second ATP. In order 
for a second ATP to bind there must be a high concentration of ATP (more energy) and when it 
does bind, it opens a pore permeable to small cations. Thus, the third ATP requires even more 
energy to bind because the pore has even more of an asymmetrical conformation due to the 
binding of the second ATP. Once the third ATP binds, the pore becomes symmetric and is 
completely activated so that large molecules can enter the cell. (Pelegrín, 2011). However, the 
channel size can decrease with significantly prolonged exposure of an agonist because the 
receptor becomes dephosphorylated (North, 2002).  
The activation of P2X7 receptor can lead to many events in the cells, including the 
regulation of IL-1β and IL-18, which are important inflammatory molecules, also known as 
cytokines. First, the receptor can let in potassium cations that activate the processing of pro-ICE 
to ICE (interleukin-converting enzyme), which releases mature IL-1β. Similarly, the production 
of IL-18 occurs by processing ICE (Lister, Sharkey, Sawatzky, Hodgkiss, Davidson et al., 2007). 
It is important to note that these pathways have not yet been confirmed in animal species. These 
cytokines then activate the innate immune system, which is responsible for inflammation. In 
addition, it has been demonstrated that extended activation of P2X7 can cause apoptosis in mast 
cells and epithelial cells. Rapid apoptosis can lead to secondary necrosis, which then leads to 
even more inflammation (Lister et al., 2007). Furthermore, the P2X7 receptor is located on many 
haemopoietic cells, including macrophages and neutrophils (Lister et al., 2007). When 
lipopolysaccharides and leukotoxins trigger necrosis of cells in the lung tissue, ATP is released 
and activates the P2X7 receptor of nearby cells; which then causes inflammation and increased 
permeability via the various signaling cascades in the lung tissues that have been discussed.  
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There are five main categories of antagonists (blockers) for P2X7 receptor including: ions 
(calcium, magnesium, zinc, copper, and protons), generic antagonists (Brillant Blue G and 
oxidized ATP), large organic cations (calmidazolium and KN-62), 17β-estradiol, and some 
monoclonal antibodies. The relevant category to this study is the large organic cations, 
specifically KN-62 (a piperazine), which inhibit the P2X7 receptor reversibly and is voltage 
independent. Currently it is used to block currents via the P2X7 receptor in rats, but it does not 
seem to do the same in humans (North, 2002). Inhibitor A438079 has been used in many studies 
for the purpose of blocking ATP and BZ-ATP to study the P2X7 receptor, such as in murine 
macrophage cells (Guadalupe, 2010). 
As mentioned previously, the P2X7 receptor is capable of letting in certain dyes, such as 
ethidium and Yo-Pro. Dyes are useful in studying P2X7 because they fluoresce when they 
encounter nucleic acids within the cell. Then, their measured fluorescence can be correlated to 
how much dye entered the cell and thus indicate the degree of dilation in the receptor pore (or in 
other words, how permeable the cell is). However, some studies show that Yo-Pro takes a longer 
time to enter the pore of the P2X7 receptor compared to a normal ionic current in physiological 
conditions. These same studies indicate that there may be species differences in the uptake of 
Yo-Pro and even the blocking capabilities of antagonists (North, 2002). Therefore, it is important 
to study the effects of these molecules specifically in bovine cells to know whether their effects 
are similar or different to existing knowledge.  
 
Materials and Methodology 
 To determine whether bovine cells, specifically Mac-T cells, increase in permeability in 
response to extracellular ATP, an experiment needed to be set up in a way that fluorescence 
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values, determined by the amount of Yo-Pro entering the cells via the P2X7 receptor pore, could 
be compared between cells with ATP and cells without ATP. The negative controls had Yo-Pro, 
but no ATP in order to see the baseline fluorescence (fluorescence that was not caused by ATP) 
and this was compared to the fluorescence of the positive controls, which had Yo-Pro and ATP. 
The positive control was predicted to increase in fluorescence due to the addition of ATP, which 
would open the P2X7 pore and let in more Yo-Pro to fluoresce. The ATP needed to be incubated 
to give it time to open the P2X7 pores. The first set of experiments made the incubation time the 
variable to see how long of an incubation was required to get maximum fluorescence. This 
incubation time was used in the second set of experiments, which were designed to test how well 
the inhibitors could eliminate or reduce fluorescence by blocking ATP from binding to P2X7 so 
Yo-Pro could not enter.  To compare how well the inhibitors reduced fluorescent, cells with 
ATP, Yo-Pro, and the inhibitors were compared to positive control cells containing just Yo-Pro 
and ATP. It was predicted that the cells with the inhibitors would have lower fluorescence values 
than positive control, the cells with no inhibitors. 
 
Mac-T Cells 
 Cell media was made using DMEM with 10% fetal bovine serum, 1% L-glutamine, and 
1% antibiotics (penicillin/streptomycin). The Mac-T cell line, an immortalized bovine mammary 
gland endothelial cell line, was used for the experiments. Five vials of stock cells were kept in 
liquid nitrogen as back up cells to use when contamination occurred. When they were needed, a 
vial was thawed in a warm bath for about two and a half minutes. Once the cells were started in 
T-25 flasks, they were transferred to new T-25 flasks with fresh media once a week to ensure 
they kept growing and stayed healthy. One flask from every new cell passage was left in the 
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incubator as a back-up and the previous reserve flask was thrown away in a biohazard container. 
Of the other two flasks, one was split into three new flasks and one was used for an experiment. 
To split a flask, the old media was removed and the flask was rinsed with sterile PBS to remove 
any remaining old media. Then, trypsin was added to the flasks, to detach the cells from the flask 
surface, and it was then put in the incubator for five minutes. Once 80% of the cells detached, 
2mL of media was added to stop the trypsin reaction. The sides of the flask were rinsed off using 
the media in the flask before the media was transferred to a 15mL conical tube and centrifuged 
for five minutes at 3300 rpms. The old media was descanted into a waste beaker with 12mL of 
fresh media taking its place and the cells were re-suspended. Then, the media was aliquoted to 
new flasks. The flasks were stored in the incubator at 38˚ C.  
 
Inhibitor Stock and Working Solutions 
 The inhibitors came in a powdered form and needed to be made into stock solutions and 
working solutions. A 0.05M stock solution of inhibitor A438079 hydrochloride (inhibitor A) was 
made by adding 292 mL DMSO to the 10 mg sample of inhibitor A in its original container. 
Then, 2µL of inhibitor A stock solution was diluted with18 µL of PBS in a small tube to make a 
0.005M working solution. Likewise, a 0.05M stock solution of inhibitor KN (inhibitor K) was 
made by adding 13.9 µL of DMSO to 1mg sample of inhibitor K in its original container. Then, 
1µL of inhibitor K stock solution was diluted with 999µL PBS to make a 0.05mM working 
solution. The stock solutions were stored in a freezer at -80 degrees Celsius and the working 
solutions were stored in a refrigerator.  
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Yo-Pro and Triton Working Solutions 
The Yo-Pro was kept in the freezer at 0˚ C and was allowed to de-thaw in a dark place so 
it did not lose its fluorescence. The working solution consisted of 10uL Yo-Pro and 90uL PBS to 
make it 1.0µM solution. The working solution was stored in the refrigerator.  
 
ATP Solutions 
 An ATP solution was made out of the powdered ATP. 0.276g of powdered ATP, stored 
in the freezer, was added to 1mL distilled water to make a 0.5M solution. The pH was adjusted 
to a pH range of 6.2-6.8 by adding 0.1M NaOH. Then, the ATP solution was aliquoted to vials 
and stored in the -80 degree freezer until it was needed.  
 
Fluorescence Experiment with ATP Only 
 Mac-T cells from a confluent T-25 flask were re-suspended in 12 mL of media using the 
same procedure used in splitting the cells. However, instead of the media cell solution being 
divided into three new flasks, it was portioned out into a 24 well plate with 0.5mL cell media per 
well. The cells were incubated at 38˚ C until confluent; which took between two and three days. 
Once they were confluent, the old media was dumped out and the plate was rinsed with 300µL 
PBS twice. ATP was incubated for varying time periods of 0, 15, 30, 45, and 60 minutes before 
Yo-Pro was added. These were labeled as PC1 (positive control 1), PC2, PC3, PC4, and PC5 
respectively (figure 1). Readings were taken every 15 minutes using a fluorescent plate reader 
for 90 minutes after each initial ATP incubation period. 0.4µL ATP, to make it 1mM ATP, (ATP 
was allowed to de-thaw from -80 degree Celsius freezer before addition) was added to columns 
two through six, which was all the PC columns. 2.0 µL Yo-Pro was only added to column one, 
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negative control (NC) and two (PC1) as shown in figure 1. Immediately, the plate was placed in 
the fluorescence machine, which was set up using the Yo-Pro programming set to read at a 
wavelength of 390nm. The fluorescence of the NC and PC1 was recorded under read time 
labeled 0 minutes. After the first read, the plate was put back in the incubator. After 15 minutes, 
2.0 µL Yo-Pro was added to column three (PC2) and placed in the fluorescence machine. The 
fluorescence of the NC, PC1, and PC2 were recorded under a read time labeled 15 minutes and 0 
minute ATP incubation for the NC and PC1 and a read time labeled 0 minutes and 15 minute 
incubation for PC2. The plate was then incubated for another 15 minutes. Additional 2.0 µL of 
Yo-Pro was added every 15 minutes to a new positive control column followed by a read (of all 
the columns containing Yo-Pro). This continued until PC5 (in the last column, six) received Yo-
Pro. Then, the plate was left in the incubator where it was read every 15 minutes for another two 
hours. Therefore, fluorescence readings were taken at time points 0, 15, 30, 45, 60, 75, and 90 
minutes for the negative control and each positive control with different ATP incubation times 
(0, 15, 30, 45, and 60 minutes). 
Figure 1 
 
 
Fluorescence Experiment with ATP Only 
NC= negative control (no ATP, Yo-Pro) 
PC1= positive control (0 min. ATP 
incubation, Yo-Pro) 
PC2= positive control (15 min. ATP 
incubation, Yo-Pro) 
PC3= positive control (30 min. ATP 
incubation, Yo-Pro) 
PC4= positive control (45 min. ATP 
incubation, Yo-Pro) 
PC5= positive control (60 min. ATP 
incubation, Yo-Pro) 
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Fluorescence Experiment with ATP Inhibitors 
 Mac-T cells from a confluent T-25 flask were re-suspended in 12 mL of media using the 
same procedure used in splitting the cells. However, instead of the media cell solution being 
divided into three new flasks, it was portioned out into a 24 well plate with 0.5mL cell media per 
well. The cells were incubated at 38 degrees Celsius until confluent (little to no space between 
the cells); which took between two and three days. Once they were confluent, the old media was 
dumped out and the plate was rinsed with 300µL PBS twice. Then, 200uL of PBS (at room 
temperature) was added to each well and 0.4µL of inhibitors A438079 and KN was added to 
rows C and D respectively (figure 2). Then, the plate was incubated for 15 minutes. During that 
time the ATP was allowed to de-thaw. After the 15 minute incubation, 0.4µL ATP (to make it 
1mM ATP) was added to columns B, C, and D  (figure 2) and the plate was incubated again for 
an hour. After the second incubation, 2.0 µL Yo-Pro was added to every well. Immediately, the 
plate was placed in the fluorescence plate reader, which was set up using the Yo-Pro 
programming set to read at a wavelength of 390nm and record the fluorescence every 15 minutes 
for one hour.  
Figure 2 
 
Fluorescence Experiment with ATP 
and Inhibitors 
NC= negative control (no ATP, Yo-Pro) 
PC= positive control (only ATP) 
In. A= inhibitor A438079, ATP, Yo-Pro 
In. K= inhibitor KN, ATP, Yo-Pro 
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Data Analysis 
 In order to compare the effect of different ATP incubation periods, the data needed to be 
normalized. This was done by evaluating the positive controls against the negative control to find 
the change in fluorescence that the ATP caused. The change in fluorescence was calculated by 
dividing the positive control (Yo-Pro and ATP) fluorescence values by the negative control (Yo-
Pro and no ATP) fluorescence values. The fluorescence values for each read time for each 
positive control were divided by the negative control fluorescence value at the same read time as 
the positive control being examined. For instance, the fluorescence value at read time 30 minutes 
for PC1 was divided by the fluorescence value for the NC at its read time at 30 minutes. The 
change in fluorescent values for each read time point of each positive control were averaged 
across the three experiments to come up with a final table and graph comparing the change in 
fluorescence caused by various ATP incubation periods. This data was used to determine the 
incubation and read time for the fluorescence experiment with ATP and inhibitors. Similarly, the 
data from the fluorescent experiment with ATP and inhibitors was normalized and averaged in 
the same manner. The positive control, inhibitor A, and inhibitor K were each divided by the 
negative control at the same time point. Then the averages of each time point were calculated 
across the five experiments. 
The normalized values from the fluorescent experiment with ATP were analyzed by 
ANOVA to determine statistical significance, using a p-value in a 95% confidence interval, of 
the data set as a whole. The Scheff F-test was used to determine if significant differences existed 
between each incubation period. Also, the normalized values from the fluorescence experiment 
with ATP and inhibitors were analyzed using ANOVA to determine statistical significance using 
a p-value in a 95% confidence interval.  
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Results 
Fluorescent Experiment with ATP Only 
After running the results through an ANOVA analysis, a p-value of 0.0001 was obtained, 
meaning the data is statistically significant. As shown in Figure 3a, the greatest change in 
fluorescence was 1.954 and that was after a 60 minute ATP incubation period with a read time at 
60 minutes. In fact, the 60 minute ATP incubation period gave the greatest overall change in 
fluorescence regardless of the read time, with one exception at the initial (0 minute) read time 
where it was the second. The 45 minute ATP incubation time gave the second greatest overall 
change in fluorescence regardless of the read time, except at the initial read time where it was the 
greatest, with the highest change being 1.880. In general, the 45 and 60 minute ATP incubation 
times had much greater changes in fluorescence than the 0, 15, and 30 minute ATP incubation 
times regardless of the read time (except at the initial read time where the changes in 
fluorescence values were closer). The Scheffe F-test indicated significant differences in the 
change of fluorescence between the 45 minute ATP incubation period and the 0, 15, and 30 
minute ATP incubation periods (Figure 4). Likewise, there is a significant difference in the 
change of fluorescence between the 60 minute ATP incubation period and the 0, 15, and 30 
minute ATP incubation periods (Figure 4). There is no significant difference (0.011) between the 
45 and 60 minute ATP incubation times.  
Change of fluorescent values less than 1 mean that there was a decrease in fluorescence 
with the addition of ATP. This occurred once at the 0 minute read time point, where it was 0.968. 
Further, the 0 minute ATP incubation time had the lowest changes for five of the seven read 
times with it only ever reaching 1.234. However, the 0, 15, and 30 minute ATP incubation 
periods were similar in their change of fluorescence, having no significant differences (Figure 4). 
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Looking strictly at the read time points for every incubation period, the greatest change 
takes place between the 0 and 30 minute read times, then after that it stays about the same in the 
degree of change in fluorescence between read time points.  
  Figure 3a 
Data Table for Effect of ATP 
Incubation Period and Read Time on 
Yo-Pro Fluorescence    
    
ATP Incubation Period 
(minutes) 
  0 15 30 45 60 
 0 1.137 0.968 1.046 1.405 1.18 
 15 1.256 1.18 1.199 1.583 1.688 
Read Time 30 1.146 1.258 1.244 1.772 1.877 
(minutes) 45 1.207 1.259 1.312 1.846 1.917 
 60 1.163 1.393 1.44 1.88 1.954 
 75 1.177 1.389 1.389 1.823 1.87 
 90 1.234 1.328 1.309 1.77 1.837 
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Fluorescent Experiment with ATP and Inhibitors 
After running the results through an ANOVA analysis, a p-value of 0.8573 was obtained, 
meaning the data is statistically insignificant. This was expected after graphing the data obtained 
from the experiment. As seen in figure 5, there is little to no difference between the control and 
each of the inhibitors. Additionally, there is little to no difference between the read times for the 
control, inhibitor A, and inhibitor K. Even though there is no significance, some trends can be 
seen. Inhibitor A is consistently greater than the positive control and inhibitor K is lower than the 
positive control in the last three read times. 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 4 
Comparison of Entire 
ATP Incubation Periods 
       ATP Incubation Period     Mean  Standard Error  
0 1.188 0.035 
15 1.254 0.037 
30 1.279 0.034 
45 1.735* 0.158 
60 1.76* 0.102 
*difference with 0, 15, and 30 period determined significant at 95% by Scheffe F-test 
Figure 5a 
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Discussion 
Fluorescent Experiment with ATP Only 
 The experiment’s purpose was to determine the optimal fluorescence that can be achieved 
with the right ATP incubation period and read time combination so more information can be 
known about the interaction between ATP the P2X7 receptor. Plus, the results served as a 
guideline for setting up the protocol to test inhibitors of ATP because the ATP incubation period 
and read time with the highest fluoresce needed to be used to make sure the inhibitor can block 
ATP at ATP’s peak effectiveness. From the results, it shows that the optimal fluorescence occurs 
after a 60 minute ATP incubation period and a 60 minute read time. This means that it takes a 
total of 120 minutes for ATP to bind to the P2X7 receptor in a manner that allows the maximum 
amount of Yo-Pro to enter the cell. In general, the results show an increase in fluorescence as the 
ATP incubation period increases, meaning it takes a certain amount of time for ATP to open 
Data Table for Inhibitors on  ATP Induced 
Yo-Pro Fluorescence    
              0 min  15 min    30 min   45 min  60 min 
Positive control 1.202 1.139 1.16 1.171 1.18 
Inhibitor A 1.208 1.166 1.187 1.207 1.192 
Inhibitor K 1.279 1.151 1.125 1.127 1.133 
*significant at 95% 
Figure 5b 
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P2X7’s pore. This supports previous evidence claiming that there is a time-dependent increase in 
permeability. Specifically, a new model proposes that P2X7’s pore expands as more ATP binds 
to it. Without ATP, the P2X7 receptor is closed, symmetrical, and has a high affinity for ATP, 
causing ATP to bind when it is around. Once one ATP is bound, a conformation change happens 
so the receptor becomes asymmetrical and has a low affinity for ATP (making it hard for more 
ATP to bind). When the second ATP does bind, it causes another conformational shift and 
lowers the affinity for ATP even more. Thus, it takes a lot to get the third ATP bound to the 
receptor. When it does, the receptor becomes symmetrical again and the new conformation has a 
wide enough pore for large molecules, like Yo-Pro, to go into the cell (Pelegrín et al., 2011). 
Based on the results obtained that fluorescence increases with increased ATP incubation 
(meaning more pores are open after a longer ATP incubation period), it is possible this is the 
mechanism taking place in bovine Mac-T cells. There were no significant changes in 
fluorescence for the first 30 minutes of incubation, meaning this is when the first two ATP’s 
were binding to the receptor because most of the pores were still closed so not as much Yo-Pro 
could enter cells to fluoresce. Once the third ATP had time to bind, there was a significant 
change in fluorescence (resulting from much more Yo-Pro entering the cell because more pores 
were open), which occurred during the 45 and 60 minute incubation periods (when the third ATP 
was given enough time to bind to the receptor). The 30 minute or less incubation times were not 
enough time for the majority of the P2X7 receptors to gain that third ATP, which is why the 0, 
15, and 30 minute incubation periods had much lower fluorescence values than the 45 and 60 
minute incubation periods. In addition, the fluorescence correlates with the cell’s permeability 
because more fluorescence is a result of more Yo-Pro entering the cell, which means the P2X7 
pore is open. The cell is more permeable when the pores are open. Yo-Pro entering the cell in 
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vitro (in a laboratory setting) represents possible biological factors and ions that could enter or 
leave a cell in vivo (in a body), which could have a part in regulating inflammation. 
Inflammation causes many of the problems associated with BRDC, including swelling in the 
lung tissues and clogging of the airways with fluid and cellular debris. By knowing the 
mechanism of action of ATP and how it leads to inflammation is crucial in the path to being able 
to better treat and diagnose inflammatory injuries and diseases, including BRDC. 
 The additional important piece of information from this data is that there is no 
significance in the read time. In other words, it does not matter when the plate is read after its 
ATP incubation. The length of ATP incubation is more important because it showed significant 
changes. One possible reason the read time isn’t significant, is because the concentration of ATP 
does not change. Once all of the ATP has been used to bind the P2X7 receptors, there will not be 
anymore left to be used in opening more pores so no more Yo-Pro can enter and increase 
fluorescence. This is most likely the case with the 45 minute and 60 minute ATP incubation 
periods were maximum fluorescence is reached, meaning all the ATP is used. However, this 
does not have much importance related to inflammation because in vivo, the ATP concentration 
will not be limited to a certain amount. In the 0, 15, and 30 minute ATP incubation periods, not 
all of the ATP is used to bind P2X7 receptor pores to let in Yo-Pro to fluoresce. This is known 
because the fluorescence values are not as high as the 45 and 60 minute ATP incubation periods. 
Therefore, it is possible the addition of Yo-Pro somehow limits the rest of the unbound ATP in 
binding to the receptor pore because theoretically ATP should continue to bind to the receptor 
pore even after Yo-Pro has been added. This would mean a significant increase in fluorescence 
would be seen after 60 minutes of the ATP being with cells regardless of when Yo-Pro was 
added.  
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Furthermore, the initial read time (0 minutes) does not follow the same pattern as the rest 
of the read times (which is the longest incubation period at each time point having the highest 
change in fluorescence). This is mostly likely due to variance between experiments caused by the 
user. The initial read is supposed to be taken immediately once the Yo-Pro is added, but the time 
it takes to add the Yo-Pro and add the plate to the fluorescence reader can vary between 
experiments.  
 
Fluorescent Experiment with ATP and Inhibitors 
 The data from this experiment was determined not to be significant so no definite 
conclusions can be made. One reason the data is not significant is because the positive control 
did not show a large increase in fluorescence compared to the negative control, as it had 
previously done with ATP only. Therefore, it makes it difficult to determine whether the 
inhibitors were working or not because there is not a good control to compare them to. Work is 
currently being done to determine why the Mac-T cells were no longer behaving like they did in 
the initial experiment without inhibitors, including looking at the cell passage number of the cells 
(age) and the growth environment. However, there is a trend that is worth noting and to watch 
for in further experiments. Inhibitor A was consistently greater than the positive control, which 
means it did not block the ATP from binding to the P2X7 receptor. Also, inhibitor K had fairly 
consistent values that were less than the positive control, meaning that the inhibitor KN could 
potentially have an antagonist affect on ATP; although, more testing needs to be done to make 
definite conclusions.  
 
Conclusion 
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 The research conducted was aimed at trying to answer more questions about the 
mechanism that explains the interaction between ATP and the P2X7 receptor. More specifically, 
this research looked at ATP’s ability to increase a cell’s permeability by binding the P2X7 
receptor and opening its pore. Yo-Pro was used to measure the increase in permeability based on 
its ability to fluoresce once it enters a cell via the P2X7 receptor pore. The fluorescence was 
proportional to the amount of Yo-Pro in the cell and the cell’s permeability. The more 
fluorescence means more Yo-Pro, which proves more pores are open and the cell is more 
permeable. Using this logic, the relationship between the P2X7 pore and its agonist, ATP, could 
be analyzed based on time (in other words, how long it takes ATP to open the P2X7 receptor 
pore). The results showed that an incubation time period of 60 minutes gave the highest 
fluorescence, which means it took 60 minutes for enough ATP to bind and open the P2X7 pore 
to let in the fluorescent Yo-Pro. This supports the proposed mechanism of opening the P2X7 
pore, which is that the pore has to undergo three, energy-dependent (ATP) conformational 
changes before it can open. It has to have three ATP bound before it is able to let in Yo-Pro and 
this takes between 45 and 60 minutes based on the results this research found.  By knowing that 
the receptor pore goes through a slow conformational change that is dependent on the number of 
ATP bound to it, the beginning processes of inflammation can be more understood. 
Additionally, potential inhibitors of ATP were tested in their abilities to block ATP from 
binding to the P2X7 pore and thus reducing inflammation. The same logic as before was applied 
here. If ATP with inhibitors caused a lower fluorescence than ATP only, then that meant the 
inhibitors were able to block ATP so ATP couldn’t open the pore and let in Yo-Pro. The results 
obtained from this research were statistically insignificant, but a very weak positive control was 
to blame. Therefore, it cannot be concluded whether the inhibitors were effective because the 
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positive control to compare them to was insufficient. It is important to continue trying to test the 
inhibitors to determine if they have the capabilities to block ATP. They have a very important 
use in continuing to acquire knowledge about the interaction of ATP and inflammation. The 
inhibitors can be used to block ATP to determine what effects it has in the inflammation 
pathway, specifically in connection with inflammation in the lung that occurs in BRDC. 
Research comparing structural changes in the cell with ATP and with blocked ATP could be 
very useful in determining the importance of blocking extracellular ATP as a treatment option. 
Moreover, this research did have some limitations that made it difficult to analyze. The 
biggest limitation was not having consistent cell lines between experiments that would yield a 
sufficient positive control to use for comparisons. Many times the positive control would have a 
high fluorescence one week, which was ideal, and then it would be low the next week. Factors 
causing this fluctuation could not be determined, but factors that were examined include: cell 
line type, cell passage number, age of cells when the experiment was conducted, and age of ATP. 
Overall, the additional information gathered about ATP in this research can be added to 
the existing knowledge about ATP and inflammation to help other researchers studying this 
topic. Learning more about inflammation, even small amounts, brings us closer to developing 
better diagnostics and treatments. In terms of BRDC, this would reduce costs in the cattle 
industry related to mortality and low cattle weights, caused by illness. With more cattle, and 
higher quality of cattle, going to market, more beef will be produced to supply our world’s food 
demands. 
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Appendix 
Fluorescence Experiment with ATP Only 
   
Normalized 
Data      
Raw 
Data     
Experiment 
#30       
Experiment 
#30      
        ATP Incubation Period (minutes) 
  0 15 30 45 60   0 15 30 45 60 NC 
 0 0.9531 1.051 1.189 2.221 1.19  0 176.8 195 220.5 412 221 185.5 
 15 1.241 1.288 1.223 2.439 2.283  15 227.5 236 224.8 447 418.5 183.3 
Read 
Time 30 1.015 1.19 1.209 2.826 2.386 
Read 
Time 30 187.5 220 223.5 522.3 441 184.8 
(minutes) 45 1.126 1.346 1.424 2.936 2.459 (minutes) 45 201.5 241 225 525.5 440 179 
 60 1.039 1.482 1.408 2.889 2.472  60 186.5 266 252.8 518.5 443.8 179.8 
 75 1.056 1.39 1.271 2.792 2.45  75 208.8 275 251.5 552.3 444 197.8 
 90 1.064 1.375 1.306 2.732 2.261  90 208.8 276 256.3 536.3 443.8 196.3 
               
Experiment 
#34       
Experiment 
#34       
        ATP Incubation Period (minutes) 
  0 15 30 45 60   0 15 30 45 60 NC 
 0 1.36 1.001 1.119 1.156 1.432  0 183.3 135 150.8 155.8 193 134.8 
 15 1.366 1.168 1.168 1.234 1.39  15 183 137 156.5 165.3 186.3 134 
Read 
Time 30 1.412 1.247 1.324 1.266 1.815 
Read 
Time 30 185 163.3 173.5 165.8 237.8 131 
(minutes) 45 1.453 1.146 1.238 1.476 1.904 (minutes) 45 190.8 150.5 162.5 193.8 250 131.3 
 60 1.377 1.182 1.549 1.516 1.974  60 177.3 152.3 199.5 195.3 257.8 128.8 
 75 1.311 1.311 1.545 1.524 1.974  75 175 175 206.3 203.5 263.5 133.5 
 90 1.443 1.223 1.39 1.445 1.922  90 207 175.5 199.5 207.3 275.8 143.5 
               
Experiment 
#35       
Experiment 
#35       
         ATP Incubation Period (minutes) 
  0 15 30 45 60   0 15 30 45 60 NC 
 0 1.097 0.851 0.829 0.838 0.0918  0 198.8 154.3 150.3 152 166.5 181.3 
 15 1.16 1.085 1.202 1.075 1.39  15 163.3 152.8 169.3 151.3 196 140.8 
Read 
Time 30 1.01 1.336 1.198 1.225 1.429 
Read 
Time 30 144.5 161 171.3 175 204.3 143 
(minutes) 45 1.043 1.286 1.274 1.127 1.388 (minutes) 45 156 192.3 190.5 168.5 207.5 149.5 
 60 1.072 1.516 1.362 1.236 1.417  60 151 213.5 191.8 174 199.5 140.8 
 75 1.163 1.466 1.351 1.153 1.39  75 171.5 216.3 199.3 170 205 147.5 
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                                  Normalized Data                                                                                                         Raw Data 
Experiment #41     Experiment #41     
 0 min 15 min 30 min 45 min 60 min   0 min 15 min 30 min 45 min 60 min 
PC 1.688 1.308 1.355 1.38 1.372  NC 135.7 145.3 147.8 161.5 167.3 
A 1.377 1.201 1.206 1.307 1.265  PC 229 190 200.3 223 229.5 
K 1.173 1.039 1.045 1.028 1.07  A 186.8 174.5 185.8 211 211.7 
       K 159.2 150.8 154.5 166 179 
             
Experiment #43      Experiment #43     
 0 min 15 min 30 min 45 min 60 min   0 min 15 min 30 min 45 min 60 min 
PC 0.948 1.095 1.157 1.172 1.166  NC 178.2 189 194.5 209 223 
A 1.267 1.352 1.407 1.34 1.29  PC 169 207 225 245 260 
K 1.889 1.62 1.555 1.508 1.43  A 225.8 255.5 273.7 280 287.7 
       K 336.7 306.2 302.5 315.2 318.8 
             
Experiment #44      Experiment #44     
 0 min 15 min 30 min 45 min 60 min   0 min 15 min 30 min 45 min 60 min 
PC 1.082 1.085 1.041 1.037 1.07  NC 158 175.5 183.7 183.3 185.2 
A 1.063 1.044 1.029 1.082 1.105  PC 171 192.2 191.2 190 198.2 
K 1.139 0.948 0.897 0.939 0.938  A 168 183.2 189 189.3 204.7 
       K 180 166.3 164.7 172.2 173.8 
             
Experiment #45      Experiment #45     
 0 min 15 min 30 min 45 min 60 min   0 min 15 min 30 min 45 min 60 min 
PC 1.128 1.158 1.117 1.178 1.184  NC 149 159.8 168.5 171.8 173.5 
A 1.219 1.208 1.201 1.203 1.262  PC 168 185 188.2 202.3 205.5 
K 1.087 1.155 1.103 1.108 1.187  A 181.7 193 202.3 206.7 219 
       K 162 184.5 185.8 190.3 206 
             
Experiment #46      Experiment #46     
 0 min 15 min 30 min 45 min 60 min   0 min 15 min 30 min 45 min 60 min 
PC 1.163 1.048 1.126 1.089 1.106  NC 137 165 164.3 168.2 169.5 
A 1.112 1.024 1.091 1.104 1.04  PC 160.3 173 185 183.2 187.5 
K 1.109 0.994 1.024 1.051 1.041  A 153.2 169 179 185.7 176.3 
       K 152.8 164 168.2 176.8 176.5 
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